Cargando…
A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10
Hereditary hemorrhagic telangiectasia (HHT) is a potentially life-threatening genetic vascular disorder caused by loss-of-function mutations in the genes encoding activin receptor-like kinase 1 (ALK1), endoglin, Smad4, and bone morphogenetic protein 9 (BMP9). Injections of mouse neonates with BMP9/1...
Autores principales: | Ruiz, Santiago, Zhao, Haitian, Chandakkar, Pallavi, Chatterjee, Prodyot K., Papoin, Julien, Blanc, Lionel, Metz, Christine N., Campagne, Fabien, Marambaud, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118799/ https://www.ncbi.nlm.nih.gov/pubmed/27874028 http://dx.doi.org/10.1038/srep37366 |
Ejemplares similares
-
Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia
por: Tillet, Emmanuelle, et al.
Publicado: (2015) -
CDK6-mediated endothelial cell cycle acceleration drives arteriovenous malformations in hereditary hemorrhagic telangiectasia
por: Dinakaran, Sajeth, et al.
Publicado: (2023) -
Randomized, double-blind, placebo-controlled, crossover trial of oral doxycycline for epistaxis in hereditary hemorrhagic telangiectasia
por: Thompson, K. P., et al.
Publicado: (2022) -
Oxidative stress-induced MMP- and γ-secretase-dependent VE-cadherin processing is modulated by the proteasome and BMP9/10
por: Ivaldo, Caterina, et al.
Publicado: (2023) -
Effect of the CALHM1 G330D and R154H Human Variants on the Control of Cytosolic Ca(2+) and Aβ Levels
por: Vingtdeux, Valérie, et al.
Publicado: (2014)